12:00 AM
 | 
Nov 05, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Makena hydroxyprogesterone caproate injection: Postmarketing study data

Researchers at NIH and colleagues reported data from 657 women in their first pregnancy with a mid-trimester cervical length of <=30 mm showing that weekly intramuscular injections of 17 alpha-hydroxyprogesterone caproate through 36 weeks of pregnancy did not reduce the rate of preterm birth vs. placebo (25.1% vs. 24.2%). Data were published...

Read the full 240 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >